Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,421 | 842 | -317 | -10,442 | -8,609 |
| Depreciation Amortization | 124 | 2,069 | 1,016 | 5,147 | 4,568 |
| Accounts receivable | N/A | -1,708 | -11,616 | -7,542 | -13,374 |
| Other Working Capital | 1,397 | -10,729 | -10,283 | -6,957 | -22,797 |
| Other Operating Activity | -8,721 | 603 | 11,468 | 14,753 | 22,662 |
| Operating Cash Flow | $-9,621 | $-8,923 | $-9,732 | $-5,041 | $-17,550 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -680 | -272 | -1,796 | -1,493 |
| Net Acquisitions | 2,023 | 422 | -646 | 24,286 | 2,433 |
| Other Investing Activity | -1,082 | 0 | 0 | -31 | -114 |
| Investing Cash Flow | $941 | $-258 | $-918 | $22,459 | $826 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 3,047 | 4,418 | 302 | 765 |
| Debt Issued | N/A | N/A | 283 | N/A | N/A |
| Debt Repayment | -933 | -918 | -998 | -20,276 | -1,183 |
| Common Stock Issued | 54 | 37 | 18 | 92 | 80 |
| Common Stock Repurchased | N/A | N/A | N/A | -29 | -9 |
| Other Financing Activity | 5,441 | -1 | -3 | -9,889 | -46 |
| Financing Cash Flow | $4,562 | $2,165 | $3,718 | $-29,800 | $-393 |
| Exchange Rate Effect | 51 | -112 | -219 | -166 | 460 |
| Beginning Cash Position | 5,663 | 8,816 | 8,816 | 21,651 | 21,651 |
| End Cash Position | 1,596 | 1,710 | 1,888 | 8,816 | 4,809 |
| Net Cash Flow | $-4,067 | $-7,106 | $-6,928 | $-12,835 | $-16,842 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,621 | -8,923 | -9,732 | -5,041 | -17,550 |
| Capital Expenditure | N/A | -680 | -272 | -1,803 | -1,493 |
| Free Cash Flow | -9,621 | -9,603 | -10,004 | -6,844 | -19,043 |